1. Home
  2. BRLS vs SGMT Comparison

BRLS vs SGMT Comparison

Compare BRLS & SGMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BRLS
  • SGMT
  • Stock Information
  • Founded
  • BRLS 2019
  • SGMT 2006
  • Country
  • BRLS Canada
  • SGMT United States
  • Employees
  • BRLS N/A
  • SGMT N/A
  • Industry
  • BRLS
  • SGMT
  • Sector
  • BRLS
  • SGMT
  • Exchange
  • BRLS NYSE
  • SGMT Nasdaq
  • Market Cap
  • BRLS 126.8M
  • SGMT 128.5M
  • IPO Year
  • BRLS N/A
  • SGMT 2023
  • Fundamental
  • Price
  • BRLS $6.51
  • SGMT $3.24
  • Analyst Decision
  • BRLS
  • SGMT Strong Buy
  • Analyst Count
  • BRLS 0
  • SGMT 6
  • Target Price
  • BRLS N/A
  • SGMT $25.67
  • AVG Volume (30 Days)
  • BRLS 3.8K
  • SGMT 286.6K
  • Earning Date
  • BRLS 05-20-2025
  • SGMT 03-12-2025
  • Dividend Yield
  • BRLS N/A
  • SGMT N/A
  • EPS Growth
  • BRLS N/A
  • SGMT N/A
  • EPS
  • BRLS N/A
  • SGMT N/A
  • Revenue
  • BRLS $28,366,370.00
  • SGMT N/A
  • Revenue This Year
  • BRLS N/A
  • SGMT N/A
  • Revenue Next Year
  • BRLS N/A
  • SGMT N/A
  • P/E Ratio
  • BRLS N/A
  • SGMT N/A
  • Revenue Growth
  • BRLS N/A
  • SGMT N/A
  • 52 Week Low
  • BRLS $3.71
  • SGMT $2.39
  • 52 Week High
  • BRLS $10.75
  • SGMT $7.38
  • Technical
  • Relative Strength Index (RSI)
  • BRLS 57.41
  • SGMT 35.79
  • Support Level
  • BRLS $5.75
  • SGMT $3.89
  • Resistance Level
  • BRLS $6.60
  • SGMT $4.24
  • Average True Range (ATR)
  • BRLS 0.39
  • SGMT 0.24
  • MACD
  • BRLS 0.02
  • SGMT -0.00
  • Stochastic Oscillator
  • BRLS 61.43
  • SGMT 5.26

About BRLS BOREALIS FOODS INC

Borealis Foods Inc is a food technology company that has developed high-quality, affordable, sustainable, and nutritious ready-to-eat meals. It is a mission-driven company committed to utilizing its products to help solve national and global food security and nutrition challenges. Its commitment to nutrition, affordability, and sustainability reflects its goal of positively impacting both human life and the planet. Through the development and launch of its ready-made ramen, featuring 20 grams of complete plant-based protein per serving, Borealis is developing advanced solutions to address global food challenges.

About SGMT Sagimet Biosciences Inc. Series A

Sagimet Biosciences Inc is a clinical-stage biopharmaceutical company dedicated to developing a portfolio of in-house discovered, selective fatty acid synthase (FASN) inhibitors aimed at treating diseases that arise from dysfunctional lipid metabolism pathways. The company's drug candidate, denifanstat, is an oral, once-daily pill that serves as a selective FASN inhibitor under development for treating nonalcoholic steatohepatitis (NASH). The company functions as a single business segment, focusing on the development and commercialization of therapeutics for MASH and other diseases where FASN plays a pathogenic role.

Share on Social Networks: